恒瑞医药：公司SHR7280片的药品上市许可申请获国家药监局受理

Core Viewpoint - Heng Rui Medicine (600276) has received acceptance for its drug listing application for SHR7280 tablets from the National Medical Products Administration [1] Group 1 - The company announced on the evening of September 23 that it has received the acceptance notice for its drug listing application [1]